Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOnward Opps Regulatory News (ONWD)

Share Price Information for Onward Opps (ONWD)

Share Price is delayed by 15 minutes
Get Live Data
124.00    -1.00 (-0.80%)
Bid:
123.00
Ask:
125.00
Spread: 2.00 (1.626%)
Market Cap: £41.35m
ONWD Live PriceLast checked at - London Stock Exchange

Intraday Onward Opps Share Chart

Additional Subscription and Total Voting Rights

19 Jan 2026 07:00

RNS Number : 2995P
Onward Opportunities Limited
19 January 2026
Β 

The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

19 January 2026

Β 

Onward Opportunities Limited

("Onward Opportunities" or the "Company")

Β 

Additional Subscription and Total Voting Rights

Β 

Onward Opportunities Limited, the UK smaller company focussed investment company, is pleased to announce that, further to the announcement of 7.00 a.m. on 12 January 2026, and in response to additional investor demand it has raised further gross proceeds of approximately Β£0.79 million by way of an additional direct subscription (the "Additional Subscription") for 541,079 new ordinary shares (the "Additional Subscription Shares") at a price of 146.13 pence per Additional Subscription Share.

Β 

The Subscription and Additional Subscription, in aggregate, have raised gross proceeds of Β£4.51 million. The net proceeds, being approximately Β£4.40 million, will provide the Company with additional resources with which to pursue its stated investing policy.

Β 

Application has been made for the Additional Subscription Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around 22 January 2026 and the Additional Subscription Shares will, on issue, rank pari passu in all respects with the Company's existing ordinary shares.

Β 

Related Party Participation in the Additional Subscription

Β 

Dowgate Wealth Limited (the "Portfolio Manager"), the Company's Portfolio Manager and a Substantial Shareholder of the Company, has subscribed for 14,717 Additional Subscription Shares. As a result, and on Admission, the members of the Concert Party in the Company will collectively hold an aggregate of 11,578,866 ordinary shares in the Company, representing 35.32 per cent. of the Company's enlarged issued ordinary share capital, of which the Portfolio Manager holds 10,287,751 ordinary shares, representing 31.38 per cent. of the Company's enlarged issued ordinary share capital, on behalf of its discretionary clients.

Β 

The Portfolio Manager is deemed a related party of the Company pursuant to the AIM Rules for Companies (the "AIM Rules") and the Portfolio Manager's participation in the Additional Subscription constitutes a related party transaction under Rule 13 of the AIM Rules. The directors of the Company consider, having consulted with the Company's nominated adviser, that the Portfolio Manager's participation in the Additional Subscription is fair and reasonable insofar as shareholders are concerned.

Β 

Total Voting Rights

Β 

On Admission, the Company will have a total of 32,780,094 ordinary shares in issue. No ordinary shares are held in treasury. The figure of 32,780,094 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Β 

Capitalised terms not otherwise defined in the text of this announcement have the same meanings ascribed to them as in the "Issue of Equity" announcement published by the Company at 7.00 a.m. on 12 January 2026.

Β 

FOR FURTHER ENQUIRIES

Β 

Onward Opportunities Limited

Andrew Henton, Chairman

Β 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Dowgate Wealth Limited (Portfolio Manager)

Laurence Hulse, Lead Fund Manager

Β 

Tel: +44 (0)20 3416 9143

hello@dowgate.co.uk

Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)

Ben Jeynes / Seamus Fricker - Corporate Finance

Chris West / Matt Lewis - Sales and Corporate Broking

Β 

Tel: +44 (0)20 7220 0500

Dowgate Capital Limited (Joint Broker)

Russell Cook / Daniel Ingram

Tel: +44 (0)20 3903 7715

Β 

Houston (PR advisers)

Charlie Barker / Nick JackmanΒ 

Β 

Tel: +44 (0)77 3303 2695

Onward@houston.co.uk

Β 

To find out more, please visit: www.onwardopportunities.co.uk

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IOEFZGMMVVGGVZM
12
Date   Source Headline
31st Dec 202512:14 pmRNSHolding(s) in Company
4th Dec 20251:21 pmRNSDirector/PDMR Shareholding
1st Dec 20254:04 pmRNSNet Asset Value(s)
25th Nov 202511:34 amRNSHolding(s) in Company
19th Nov 20257:00 amRNSAdditional Subscription and Total Voting Rights
13th Nov 202510:32 amRNSHolding(s) in Company
6th Nov 20257:00 amRNSIssue of Equity
4th Nov 20257:00 amRNSNet Asset Value(s)
16th Oct 20254:54 pmRNSHolding(s) in Company
14th Oct 20251:09 pmRNSPublication of Q3 2025 Factsheet
10th Oct 20257:00 amRNSAdditional Subscription and Total Voting Rights
7th Oct 20257:00 amRNSIssue of Equity
1st Oct 20253:33 pmRNSNet Asset Value(s)
8th Sep 20257:00 amRNSHalf-year Report
2nd Sep 20257:00 amRNSNet Asset Value(s)
4th Aug 202512:57 pmRNSNet Asset Value(s)
25th Jul 202510:05 amRNSHolding(s) in Company
24th Jul 20257:00 amRNSHalf-Year Update
21st Jul 20257:00 amRNSAdditional Subscription and Total Voting Rights
16th Jul 20257:00 amRNSIssue of Equity
7th Jul 20257:00 amRNSPublication of Q2 2025 Factsheet
2nd Jul 20253:47 pmRNSNet Asset Value(s)
16th Jun 202512:49 pmRNSResult of AGM
3rd Jun 20257:00 amRNSNet Asset Value
2nd Jun 20257:00 amRNS-RInaugural Investor Day
29th May 20257:00 amRNSNotice of AGM
7th May 20251:29 pmRNSDirector Dealing
6th May 20257:00 amRNSChange of Service Providers and Registered Office
2nd May 20259:26 amRNSNet Asset Value(s)
16th Apr 20255:33 pmRNSHolding(s) in Company
2nd Apr 20252:50 pmRNSNet Asset Value(s)
20th Mar 20257:00 amRNSAdditional Subscription and Total Voting Rights
18th Mar 20257:00 amRNSAnnual Results
14th Mar 20257:00 amRNSIssue of Equity and Total Voting Rights
11th Mar 20255:02 pmRNSHolding(s) in Company
4th Mar 20254:59 pmRNSNet Asset Value(s)
4th Feb 20255:10 pmRNSHolding(s) in Company
4th Feb 20251:46 pmRNSNet Asset Value(s)
3rd Feb 20257:00 amRNSAmalgamation of Administrator
16th Jan 20257:00 amRNSPublication of Q4 2024 Factsheet
14th Jan 20257:00 amRNSFull-Year Update
2nd Jan 20255:50 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSAdditional Subscription and Total Voting Rights
4th Dec 20247:00 amRNSIssue of Equity
2nd Dec 20245:38 pmRNSNet Asset Value(s)
1st Nov 20244:42 pmRNSNet Asset Value(s)
30th Oct 20244:40 pmRNSHolding(s) in Company
24th Oct 202412:00 pmRNSIssue of Equity
11th Oct 20247:00 amRNSPublication of Q3 2024 Factsheet
3rd Oct 20243:44 pmRNSHolding(s) in Company
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.